Literature DB >> 8354018

Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin.

F Keller1, K Erdmann, M Giehl, P Buettner.   

Abstract

The distribution and elimination of various drugs depend on kidney function. This dependence is published either as a linear regression equation or as the discrete extreme values for normal kidney function and anuria. A meta-analysis of the published pharmacokinetic data is required to build up a knowledge-based computer system for dosage adjustment in renal failure. A sample comparison of 4 statistical methods for meta-analysis was performed by applying them to 13 publications about the aminoglycoside netilmicin. Parametric meta-analytical methods I and II are based on regression equations alone (Z-transformation, maximum likelihood) and yield unreliable data, especially with regard to extreme values for anuria. The parametric meta-analytical method III is based on means of extreme values (standard 2-stage approach) and does not permit a decision as to whether linear interpolation of a parameter (e.g. volume of distribution) can be used for all degrees of renal insufficiency. In contrast, the nonparametric median (meta-analytical method IV) is based on the extreme values calculated from regression equations and empirical extreme values combined into 1 group of data on normal kidney function and another on anuria. For netilmicin, the meta-analytical median with the 95% confidence interval (95% CI) yields a significant increase in the dominant elimination half-life from 2h (95% CI 1.9h, 2.6h) in patients with normal kidney function to 45h (95% CI 41h, 301h) in those with anuria (p = 0.001). For a normal bodyweight of 65kg, the volume of distribution also increases significantly from 13L (95% CI 9L, 15L) to 20L (95% CI 14L, 21L) in patients with anuria (p = 0.04). Thus, drug dosage adjustment according to therapeutic peak and trough concentrations requires knowledge of the distribution and elimination parameters, since they can both be independently altered in renal failure. We conclude that the most robust meta-analysis of these alterations is achieved with the nonparametric median of extreme values.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354018     DOI: 10.2165/00003088-199325010-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  27 in total

1.  Can meta-analyses be trusted?

Authors:  S G Thompson; S J Pocock
Journal:  Lancet       Date:  1991-11-02       Impact factor: 79.321

2.  Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.

Authors:  C E Halstenson; C A Hirata; K L Heim-Duthoy; P A Abraham; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

4.  Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

5.  Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharm Sci       Date:  1982-12       Impact factor: 3.534

Review 6.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Pharmacokinetics of vigabatrin: implications of creatinine clearance.

Authors:  K D Haegele; N D Huebert; M Ebel; G P Tell; P J Schechter
Journal:  Clin Pharmacol Ther       Date:  1988-11       Impact factor: 6.875

8.  Clinical use of a one-compartment model for determining netilmicin pharmacokinetic parameters and dosage recommendations.

Authors:  J C Rotschafer; K B Crossley; D E Zaske; N J Russillo; R G Strate; R W Tofte; L D Solem
Journal:  Ther Drug Monit       Date:  1983       Impact factor: 3.681

9.  Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.

Authors:  G Humbert; A Leroy; J P Fillastre; G Oksenhendler
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

10.  Pharmacokinetics of netilmicin in hypertonic hemodiafiltration and standard hemodialysis.

Authors:  C Basile; A Di Maggio; E Curino; A Scatizzi
Journal:  Clin Nephrol       Date:  1985-12       Impact factor: 0.975

View more
  2 in total

Review 1.  Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?

Authors:  M M Tod; C Padoin; O Petitjean
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients.

Authors:  Nicolas Charhon; Michael N Neely; Laurent Bourguignon; Pascal Maire; Roger W Jelliffe; Sylvain Goutelle
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.